2m 2m 2m 2m 2m 2m 2m
FORTRESS BIOTCH (FBIO)
NASDAQ
$2.54+$0.02 (+0.60%)
Price as of Sep 11, 2026 7:59 PM EDT- $84.0MMarket Cap
- -35.22%1-Year Change
- BiotechnologyIndustry
FORTRESS BIOTCH (FBIO)
$2.54+$0.02 (+0.60%)
FBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.52 | ||
Change | -$0.05 (-1.95%) | ||
Open | $2.59 | ||
High | $2.62 | ||
Low | $2.52 | ||
Previous Close | $2.57 | ||
Volume | 209,700 | ||
30-Day Average Volume | 488,490 | ||
1-Week Change | -7.35% | ||
1-Month Change | -3.45% | ||
1-Year Change | -35.22% | ||
3-Year Change | -54.19% | ||
5-Year Change | -94.99% | ||
Fundamentals | |||
Shares Outstanding | 33.4M | ||
Total Assets | $316.7M | ||
Market Cap | $84.0M | ||
Enterprise Value | -$72.9M | ||
Period: QTR TTM FY | |||
Revenue | $18.7M | ||
Net Income | -$468,000.00 | ||
Free Cash Flow | -$59.3M | ||
EBIT | $1.3M | ||
EBITDA | $2.3M | ||
Net Working Capital | $183.5M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -32 | ||
Enterprise Value/Revenue | -4 | ||
P/B | 1 | ||
P/E | -32 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 10/10/2023 | ||
Earnings & Revenue